Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T Geller,Michal Barzily-Rokni,Tal Danino,Oliver H Jonas,Noam Shental,Deborah Nejman,Nancy Gavert,Yaara Zwang,Zachary A Cooper,Kevin Shee,Christoph A Thaiss,Alexandre Reuben,Jonathan Livny,Roi Avraham,Dennie T Frederick,Matteo Ligorio,Kelly Chatman,Stephen E Johnston,Carrie M Mosher,Alexander Brandis,Garold Fuks,Candice Gurbatri,Vancheswaran Gopalakrishnan,Michael Kim,Mark W Hurd,Matthew Katz,Jason Fleming,Anirban Maitra,David A Smith,Matt Skalak,Jeffrey Bu,Monia Michaud,Sunia A Trauger,Iris Barshack,Talia Golan,Judith Sandbank,Keith T Flaherty,Anna Mandinova,Wendy S Garrett,Sarah P Thayer,Cristina R Ferrone,Curtis Huttenhower,Sangeeta N Bhatia,Dirk Gevers,Jennifer A Wargo,Todd R Golub,Ravid Straussman,Leore T. Geller,Oliver H. Jonas,Zachary A. Cooper,Christoph A. Thaiss,Dennie T. Frederick,Stephen E. Johnston,Carrie M. Mosher,Mark W. Hurd,David A. Smith,Sunia A. Trauger,Keith T. Flaherty,Wendy S. Garrett,Sarah P. Thayer,Cristina R. Ferrone,Sangeeta N. Bhatia,Jennifer A. Wargo,Todd R. Golub
DOI: https://doi.org/10.1126/science.aah5043
IF: 56.9
2017-09-15
Science
Abstract:In model systems, bacteria present in human pancreatic tumors confer resistance to the anticancer drug gemcitabine.
multidisciplinary sciences